Vivanza Biosciences Ltd — Updates, 11-04-2025: Company Update

Vivanza Biosciences Limited has confirmed the non-applicability of the Statement of Deviation or Variation in line with SEBI regulations, noting that it has not raised additional funds through public, rights, or preferential issues. This update indicates stable financial management and adherence to compliance standards. The absence of new fundraising activities suggests a focus on organic growth rather than external capital, which may maintain shareholder confidence. Investors might view this as a neutral impact, as the company appears to prioritize existing resources while limiting dilution risks.